D.E. Shaw & Co’s Argan AGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.25M Sell
7,800
-2,600
-25% -$1.06M ﹤0.01% 2294
2025
Q4
$3.26M Buy
10,400
+200
+2% +$63.5K ﹤0.01% 2664
2025
Q3
$2.75M Sell
10,200
-5,700
-36% -$1.31M ﹤0.01% 2724
2025
Q2
$3.51M Buy
15,900
+6,700
+73% +$1.21M ﹤0.01% 2302
2025
Q1
$1.21M Buy
9,200
+7,500
+441% +$1.05M ﹤0.01% 2973
2024
Q4
$233K Buy
+1,700
New +$234K ﹤0.01% 4012
2014
Q2
Sell
-30,000
Closed -$892K 4142
2014
Q1
$892K Buy
+30,000
New +$863K ﹤0.01% 3133

Other funds holding AGX

D.E. Shaw & Co's AGX Position: Q1 2026 in Review

D.E. Shaw & Co increased its Argan (AGX) stake by 256% in Q1 2026, buying an estimated $3.66M and bringing the position to 12,499 shares worth $6.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

D.E. Shaw & Co first reported a position in AGX in Q2 2014 and has held it in 18 quarters since. 495 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • D.E. Shaw & Co held 12,499 shares of Argan worth $6.81M as of Q1 2026.
  • D.E. Shaw & Co bought 8,987 Argan shares in Q1 2026, an estimated $3.66M.
  • Argan made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1943 holding.
  • D.E. Shaw & Co first reported a position in Argan in Q2 2014 and has held it in 18 quarters since.
  • 495 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.